Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Three-day GnRH antagonist pretreatment before IVF antagonist protocol
ChiCTR1800019730Phase 4Recruiting
- Sponsor
- Guangxi Zhuang Autonomous Region People's Hospital
- Start
- Dec 2018
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of relugolix in infertility (2 arms), sponsored by Guangxi Zhuang Autonomous Region People's Hospital. Primary endpoint: Oocyte number. Started Dec 2018; status: recruiting.
02
Drugs
relugolix
03
Conditions
infertility
Beyond the preview
Go deeper on ChiCTR1800019730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019730.